Dasatinib 100 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB26FX3TB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,723
Award facts
- Contract value 100% obligated
- $17,723.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Dasatinib 100 mg tablets (30-count units) with a contract ceiling value of $17,723.13. This is a firm fixed-price delivery order with an ultimate completion date of October 24, 2025, and is not designated as a set-aside contract. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The company holds a significant competitive position as a prime vendor for DLA Medical Supply Chain operations, delivering medications across multiple therapeutic domains including specialty pharmaceuticals, brand-name and generic drugs, vaccines, and medical devices. This delivery order for Dasatinib, a targeted cancer therapy medication, exemplifies the company's role in fulfilling federal oncology and specialty pharmaceutical requirements within the broader strategic pharmaceutical sourcing initiative managed by DLA Troop Support.
Quick answers
Who was awarded contract SPE2DB26FX3TB?
SPE2DB26FX3TB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 23, 2025.
How much is contract SPE2DB26FX3TB worth?
The government has obligated $17,723 on SPE2DB26FX3TB.
Is contract SPE2DB26FX3TB an order under another contract?
Yes. SPE2DB26FX3TB is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB26FX3TB competed?
The extent of competition for SPE2DB26FX3TB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award